Key Points
- Director Mark Parkinson sold 100 ENSG shares for approximately $17,962 under a pre-arranged Rule 10b5-1 plan, reducing his holdings by 2.22% to 4,400 shares.
- The Ensign Group reported quarterly EPS of $1.92, beating estimates by $0.12, while revenue rose 16.7% year over year to $1.44 billion. The company also issued fiscal 2026 EPS guidance of $7.75–$7.85.
- Shares opened at $173.05, and analysts maintain a “Moderate Buy” consensus with an average price target of $216.25. The company declared a quarterly dividend of $0.065 per share, while several securities-fraud class-action notices have introduced legal concerns for investors.
The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report) Director Mark Parkinson sold 100 shares of the business's stock in a transaction dated Friday, October 16th. The shares were sold at an average price of $179.62, for a total transaction of $17,962.00. Following the completion of the sale, the director directly owned 4,400 shares of the company's stock, valued at $790,328. This represents a 2.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
The Ensign Group Stock Down 2.0%
Shares of NASDAQ ENSG opened at $173.05 on Tuesday. The Ensign Group, Inc. has a 52 week low of $141.58 and a 52 week high of $218.00. The stock's fifty day moving average is $175.21 and its 200 day moving average is $175.22. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21. The stock has a market capitalization of $10.09 billion, a P/E ratio of 27.12, a PEG ratio of 1.67 and a beta of 0.66.
The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.80 by $0.12. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business's quarterly revenue was up 16.7% compared to the same quarter last year. During the same period last year, the firm earned $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Sell-side analysts forecast that The Ensign Group, Inc. will post 7.04 earnings per share for the current fiscal year.
The Ensign Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, October 31st. Investors of record on Wednesday, September 30th will be paid a $0.0650 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Wednesday, September 30th. The Ensign Group's dividend payout ratio (DPR) is 4.08%.
Institutional Investors Weigh In On The Ensign Group
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new position in The Ensign Group in the second quarter valued at about $937,218,000. Wasatch Advisors LP boosted its stake in shares of The Ensign Group by 10.7% during the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company's stock valued at $365,215,000 after purchasing an additional 220,329 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of The Ensign Group by 7.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company's stock worth $92,220,000 after purchasing an additional 30,521 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of The Ensign Group during the second quarter worth about $65,470,000. Finally, Paradigm Capital Management Inc. NY bought a new stake in shares of The Ensign Group during the second quarter worth about $54,742,000. Institutional investors own 96.12% of the company's stock.
Trending Headlines about The Ensign Group
Here are the key news stories impacting The Ensign Group this week:
- Positive Sentiment: No new negative operating announcement was reported. Ensign’s most recent results showed earnings above expectations, double-digit revenue growth and fiscal 2026 EPS guidance of $7.75–$7.85, providing fundamental support. The Ensign Group Is Healthy, But Not Worth Buying
- Neutral Sentiment: Director Mark Parkinson sold 100 shares for approximately $17,962, reducing his ownership by 2.22%. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which makes it a limited insider signal; he continues to own 4,400 shares. SEC insider transaction filing
- Negative Sentiment: Rosen Law Firm announced that it filed a securities-fraud class action covering investors who purchased Ensign securities from February 10, 2022, through June 18, 2026. Investors are being asked to seek lead-plaintiff status by December 7, 2026. Rosen Law Firm lawsuit announcement
- Negative Sentiment: Kaplan Fox, Wolf Haldenstein, Bronstein Gewirtz & Grossman, Bleichmar Fonti & Auld and other firms issued substantially similar notices regarding the same pending class action. The repeated headlines may amplify investor concern about potential damages, legal costs and disclosure-related issues, even though they do not represent separate proven findings. Kaplan Fox class action notice
- Negative Sentiment: A Seeking Alpha article characterized Ensign as financially healthy but not attractive to buy, adding a bearish valuation opinion to the litigation-related selling pressure. The Ensign Group Is Healthy, But Not Worth Buying
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on ENSG shares. Wall Street Zen cut The Ensign Group from a "buy" rating to a "hold" rating in a research note on Saturday. Royal Bank Of Canada reiterated an "outperform" rating and issued a $228.00 price target on shares of The Ensign Group in a research note on Tuesday, July 28th. Truist Financial lifted their price target on The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a research note on Thursday, July 30th. Finally, Weiss Ratings raised The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $216.25.
View Our Latest Research Report on The Ensign Group
The Ensign Group Company Profile
(
Get Free Report)
The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.
Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.
Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
